daraxonrasib: The New Medicare Rule Secretly Changing Your Drug Prices
If you’ve been scratching your head over rising prescription costs, meet daraxonrasib—the obscure word that could save or cost you hundreds. A new federal rule references this term, and consumer watchdogs say it’s quietly allowing drugmakers to hike copays on common medications while slashing rebates. For your wallet, this means checking your next pharmacy receipt: some patients report a 30% jump in out-of-pocket costs for previously affordable generics. Until Congress clarifies daraxonrasib’s loopholes, always ask your pharmacist for cheaper alternatives. Spread the word—your neighbor’s budget might depend on it.